Get started
Author

Tarek Z. Bass

Observed name: Tarek Bass
ORCID: 0000-0003-1598-8894
Observed ORCID: 0000-0003-1598-8894
OpenAlex ID: A5000730066
Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
2013 · Magdalena Malm, Nina Kronqvist, et al. · PLoS ONE · 71
PDF
Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells
2019 · Nicola Fenderico, Revina C. van Scherpenzeel, et al. · Nature Communications · 67
PDF
Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin‐binding domain allows for affinity purification and in vivo half‐life extension
2014 · Magdalena Malm, Tarek Bass, et al. · Biotechnology Journal · 52
A Lateral Flow Protein Microarray for Rapid and Sensitive Antibody Assays
2011 · Jesper Gantelius, Tarek Bass, et al. · International Journal of Molecular Sciences · 38
PDF
Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111
2019 · Sara S. Rinne, Charles Dahlsson Leitao, et al. · Scientific Reports · 35
PDF
Evaluation of the Therapeutic Potential of a HER3-Binding Affibody Construct TAM-HER3 in Comparison with a Monoclonal Antibody, Seribantumab
2018 · Anna Orlova, Tarek Z. Bass, et al. · Molecular Pharmaceutics · 25
In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin-binding therapeutic affibody construct
2017 · Tarek Z. Bass, Maria Rosestedt, et al. · Scientific Reports · 19
PDF
Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
2013 · Magdalena Malm, Nina Kronqvist, et al. · PLoS ONE · 17
Evaluating the therapeutic potential of a dimeric HER3-binding affibody construct in comparison with a monoclonal antibody, seribantumab.
2017 · Tarek Bass · KTH Publication Database DiVA (KTH Royal Institute of Technology) · 1
Affibody molecules targeting HER3 for cancer therapy
2017 · Tarek Bass · KTH Publication Database DiVA (KTH Royal Institute of Technology) · 1
In vivo evaluation of pharmacokinetics, tumors targeting and therapeutic efficacy of a novel format of HER3-targeting affibody molecule with prolonged blood circulation
2016 · Anna Orlova, Maria� Rosestedt, et al. · European Journal of Nuclear Medicine and Molecular Imaging
A ten-minute high density lateral flow protein microarray assay
2011 · Jesper Gantelius, Tarek Bass, et al.
Towards highly multiplexed point-of-care, the lateral flow microarray
2011 · Tarek Bass
Works count: 14
Citation count: 326
H-index: 8
I10-index: 8
Year
Topic
Type